Karyopharm Therapeutics Inc.
Climate Impact & Sustainability Data (2016, 2021, 2022)
Reporting Period: 2016
Environmental Metrics
Climate Goals & Targets
Supply Chain Management
Climate-Related Risks & Opportunities
Reporting Period: 2021
Environmental Metrics
Total Carbon Emissions:Not disclosed
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:Not disclosed
Water Consumption:Not disclosed
Waste Generated:Not disclosed
Carbon Intensity:Not disclosed
ESG Focus Areas
- Environmental
- Social
- Governance
Environmental Achievements
- Reduced waste through reuse of packaging materials and recycling of paper, hard plastic, and cardboard; switched from plastic tape to paper tape for packing shipments.
- Installed electric vehicle charging stations at corporate headquarters (planned for 2021).
Social Achievements
- Donated PPE and supplies to hospitals and non-profit organizations.
- Initiated a global clinical trial to evaluate selinexor as a potential treatment for COVID-19.
- Provided employees with meal vouchers and resources to support remote work.
- Offered a comprehensive benefits package including medical, dental, vision, life insurance, and retirement plans.
- Implemented training, development, and engagement programs including annual goal setting, employee engagement surveys, and stock-award recognition.
- Engaged in dialogue on diversity initiatives.
- Offered mentorship and paid internship programs.
- Sponsored local youth programs.
- Made annual charitable donations.
- Offered free learning webinars to communities.
- Supported a company-wide volunteer program.
- Launched KaryForward patient support program providing assistance with insurance coverage, copay assistance, and nurse case management.
Governance Achievements
- Developed a comprehensive compliance program with a Chief Compliance Officer reporting directly to the General Counsel and having access to the Board of Directors.
- Established a Compliance Committee to oversee healthcare-related regulatory and compliance matters.
- Implemented annual compliance training for all employees on the Code of Ethics and Business Conduct, including anti-harassment and anti-discrimination training.
- Developed a policy dedicated to the Foreign Corrupt Practices Act and Anti-Corruption.
- Established a Compliance Hotline for anonymous reporting.
- Adopted a Code of Ethics and Business Conduct, Corporate Governance Guidelines, and charters for various committees.
- Maintained a predominantly independent Board of Directors with diverse skills, experience, and backgrounds.
Climate Goals & Targets
Long-term Goals:
- Not disclosed
Medium-term Goals:
- Not disclosed
Short-term Goals:
- Not disclosed
Environmental Challenges
- Not disclosed
Mitigation Strategies
- Not disclosed
Supply Chain Management
Supplier Audits: Not disclosed
Responsible Procurement
- Not disclosed
Climate-Related Risks & Opportunities
Physical Risks
- Not disclosed
Transition Risks
- Not disclosed
Opportunities
- Not disclosed
Reporting Standards
Frameworks Used: Null
Certifications: Null
Third-party Assurance: Not disclosed
UN Sustainable Development Goals
- Not disclosed
Not disclosed
Sustainable Products & Innovation
- Not disclosed
Awards & Recognition
- Not disclosed
Reporting Period: 2022
Environmental Metrics
ESG Focus Areas
- Corporate Responsibility
- Sustainability
- Diversity and Inclusion
Environmental Achievements
- Providing electric vehicle charging stations for employees at corporate headquarters
Social Achievements
- Continuing support for scientific, medical, patient, and local communities; sponsoring local youth programs; supporting patient community needs in response to natural disasters; enabling employee participation in charity events; implementing company-wide diversity initiatives, including a Dialogue on Diversity program; partnering with LGBTQ professional groups and local organizations to access diverse talent; establishing key working relationships with local universities to build diversity in the internship program.
Governance Achievements
- Strengthening consideration of diversity factors when evaluating potential director nominees; engaging a third-party advisory firm to conduct the 2022 Board and committee self-evaluation; adopting a compensation recovery (clawback) policy; adopting a Related Person Transaction Policy.
Climate Goals & Targets
Environmental Challenges
- Maintaining a competitive position by attracting, retaining, and motivating key employees with experience and ability in a challenging talent market; balancing equity compensation needs against dilutive effects on stockholders; managing the dilutive impact of the equity award program.
Mitigation Strategies
- Implementing competitive total compensation and benefits; amending the 2022 Equity Incentive Plan to increase the share pool; carefully managing the equity compensation program by reviewing market data and ensuring competitive pay packages; implementing performance-based RSUs (PSUs); adopting a clawback policy.